Logo image of CS.PA

AXA SA (CS.PA) Stock Fundamental Analysis

EPA:CS - Euronext Paris - Matif - FR0000120628 - Common Stock - Currency: EUR

41.46  +0.39 (+0.95%)

Fundamental Rating

5

Taking everything into account, CS scores 5 out of 10 in our fundamental rating. CS was compared to 37 industry peers in the Insurance industry. Both the profitability and the financial health of CS get a neutral evaluation. Nothing too spectacular is happening here. CS has a correct valuation and a medium growth rate. Finally CS also has an excellent dividend rating. This makes CS very considerable for dividend investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CS was profitable.
CS had a positive operating cash flow in the past year.
Each year in the past 5 years CS has been profitable.
CS had a positive operating cash flow in each of the past 5 years.
CS.PA Yearly Net Income VS EBIT VS OCF VS FCFCS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

CS has a better Return On Assets (1.18%) than 62.16% of its industry peers.
With a decent Return On Equity value of 15.39%, CS is doing good in the industry, outperforming 67.57% of the companies in the same industry.
With a decent Return On Invested Capital value of 1.33%, CS is doing good in the industry, outperforming 64.86% of the companies in the same industry.
CS had an Average Return On Invested Capital over the past 3 years of 1.29%. This is in line with the industry average of 2.10%.
The 3 year average ROIC (1.29%) for CS is below the current ROIC(1.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.18%
ROE 15.39%
ROIC 1.33%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
CS.PA Yearly ROA, ROE, ROICCS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CS has a Profit Margin of 8.80%. This is comparable to the rest of the industry: CS outperforms 48.65% of its industry peers.
CS's Profit Margin has improved in the last couple of years.
The Operating Margin of CS (12.32%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CS has grown nicely.
Industry RankSector Rank
OM 12.32%
PM (TTM) 8.8%
GM N/A
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
CS.PA Yearly Profit, Operating, Gross MarginsCS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

5

2. Health

2.1 Basic Checks

CS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CS has less shares outstanding
Compared to 5 years ago, CS has less shares outstanding
The debt/assets ratio for CS is higher compared to a year ago.
CS.PA Yearly Shares OutstandingCS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CS.PA Yearly Total Debt VS Total AssetsCS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B

2.2 Solvency

Based on the Altman-Z score of 0.35, we must say that CS is in the distress zone and has some risk of bankruptcy.
With an excellent Altman-Z score value of 0.35, CS belongs to the best of the industry, outperforming 89.19% of the companies in the same industry.
CS has a debt to FCF ratio of 2.19. This is a good value and a sign of high solvency as CS would need 2.19 years to pay back of all of its debts.
The Debt to FCF ratio of CS (2.19) is better than 75.68% of its industry peers.
CS has a Debt/Equity ratio of 0.53. This is a neutral value indicating CS is somewhat dependend on debt financing.
CS has a better Debt to Equity ratio (0.53) than 70.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 2.19
Altman-Z 0.35
ROIC/WACC0.13
WACC10.48%
CS.PA Yearly LT Debt VS Equity VS FCFCS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

CS has a Current Ratio of 0.87. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
CS has a Current ratio of 0.87. This is amongst the best in the industry. CS outperforms 89.19% of its industry peers.
CS has a Quick Ratio of 0.87. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
CS's Quick ratio of 0.87 is amongst the best of the industry. CS outperforms 89.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.87
CS.PA Yearly Current Assets VS Current LiabilitesCS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.08% over the past year.
The Earnings Per Share has been growing by 18.09% on average over the past years. This is quite good.
Looking at the last year, CS shows a small growth in Revenue. The Revenue has grown by 4.38% in the last year.
The Revenue has been decreasing by -8.16% on average over the past years.
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%

3.2 Future

CS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.32% yearly.
CS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.73% yearly.
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y6.32%
Revenue Next Year6.29%
Revenue Next 2Y5.45%
Revenue Next 3Y2.6%
Revenue Next 5Y7.73%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CS.PA Yearly Revenue VS EstimatesCS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B 80B 100B
CS.PA Yearly EPS VS EstimatesCS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

CS is valuated reasonably with a Price/Earnings ratio of 11.55.
Compared to the rest of the industry, the Price/Earnings ratio of CS indicates a somewhat cheap valuation: CS is cheaper than 70.27% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.20. CS is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 10.35, the valuation of CS can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CS indicates a somewhat cheap valuation: CS is cheaper than 72.97% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CS to the average of the S&P500 Index (22.13), we can say CS is valued rather cheaply.
Industry RankSector Rank
PE 11.55
Fwd PE 10.35
CS.PA Price Earnings VS Forward Price EarningsCS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

CS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CS is cheaper than 67.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.66
EV/EBITDA N/A
CS.PA Per share dataCS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1
PEG (5Y)0.64
EPS Next 2Y9.13%
EPS Next 3Y8.44%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.16%, CS is a good candidate for dividend investing.
CS's Dividend Yield is a higher than the industry average which is at 4.50.
Compared to an average S&P500 Dividend Yield of 2.40, CS pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.16%

5.2 History

The dividend of CS is nicely growing with an annual growth rate of 8.12%!
Dividend Growth(5Y)8.12%
Div Incr Years3
Div Non Decr Years3
CS.PA Yearly Dividends per shareCS.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

CS pays out 57.97% of its income as dividend. This is a bit on the high side, but may be sustainable.
CS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP57.97%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
CS.PA Yearly Income VS Free CF VS DividendCS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
CS.PA Dividend Payout.CS.PA Dividend Payout, showing the Payout Ratio.CS.PA Dividend Payout.PayoutRetained Earnings

AXA SA

EPA:CS (5/29/2025, 7:00:00 PM)

41.46

+0.39 (+0.95%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)03-19 2025-03-19/bmo
Earnings (Next)08-01 2025-08-01
Inst Owners36.79%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap91.84B
Analysts80.74
Price Target43.3 (4.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.16%
Yearly Dividend2.02
Dividend Growth(5Y)8.12%
DP57.97%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.12%
PT rev (3m)6.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)6.74%
Valuation
Industry RankSector Rank
PE 11.55
Fwd PE 10.35
P/S 1.05
P/FCF 7.66
P/OCF 7.37
P/B 1.84
P/tB 3.35
EV/EBITDA N/A
EPS(TTM)3.59
EY8.66%
EPS(NY)4.01
Fwd EY9.66%
FCF(TTM)5.41
FCFY13.06%
OCF(TTM)5.63
OCFY13.58%
SpS39.43
BVpS22.55
TBVpS12.36
PEG (NY)1
PEG (5Y)0.64
Profitability
Industry RankSector Rank
ROA 1.18%
ROE 15.39%
ROCE 1.67%
ROIC 1.33%
ROICexc 1.37%
ROICexgc 1.79%
OM 12.32%
PM (TTM) 8.8%
GM N/A
FCFM 13.73%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
ROICexc(3y)1.34%
ROICexc(5y)1.16%
ROICexgc(3y)1.75%
ROICexgc(5y)1.48%
ROCE(3y)1.62%
ROCE(5y)1.41%
ROICexcg growth 3Y10.47%
ROICexcg growth 5Y16.55%
ROICexc growth 3Y8.69%
ROICexc growth 5Y14.36%
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 2.19
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.54%
Interest Coverage 1.72
Cash Conversion N/A
Profit Quality 156.03%
Current Ratio 0.87
Quick Ratio 0.87
Altman-Z 0.35
F-Score7
WACC10.48%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)104.89%
Profit Quality(5y)238.88%
High Growth Momentum
Growth
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y6.32%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%
Revenue Next Year6.29%
Revenue Next 2Y5.45%
Revenue Next 3Y2.6%
Revenue Next 5Y7.73%
EBIT growth 1Y18.59%
EBIT growth 3Y2.9%
EBIT growth 5Y10.41%
EBIT Next Year25.76%
EBIT Next 3Y11.02%
EBIT Next 5YN/A
FCF growth 1Y240.94%
FCF growth 3Y7.74%
FCF growth 5Y9.94%
OCF growth 1Y216.74%
OCF growth 3Y7.85%
OCF growth 5Y9.48%